| 2026-06-05 | 8-K | 10.1 | NovoCure Limited Amended and Restated 2024 Omnibus Incentive Plan |
|---|
| 2026-04-30 | 10-Q | 10.2 | Termination Agreement by and between Novocure GmbH and Nicolas Leupin dated February 23, 2026# |
|---|
| 2026-04-24 | 8-K/A | 10.1 | Employment Agreement between Frank Leonard and Novocure GmbH effective as of January 1, 2026 |
|---|
| 2026-02-26 | 10-K | 10.26 | Non-Employee Director Compensation Program |
|---|
| 2025-12-01 | 8-K | 10.1 | Cordova Separation Agreement |
|---|
| 2025-06-06 | 8-K | 10.1 | NovoCure Limited 2025 Employee Share Purchase Plan |
|---|
| 2025-04-24 | 10-Q | 10.1 | Employment Agreement between Uri Weinberg and Novocure GmbH effective as of August 1, 2024# |
|---|
| 2025-02-27 | 10-K | 10.51 | Forms of Performance-Based Restricted Share Unit Award under 2024 Omnibus Incentive Plan# |
|---|
| 2025-02-27 | 10-K | 10.50 | Forms of Restricted Share Unit Award Notice under 2024 Omnibus Incentive Plan# |
|---|
| 2025-02-27 | 10-K | 10.49 | Forms of Share Option Agreement under 2024 Omnibus Incentive Plan# |
|---|
| 2025-02-27 | 10-K | 10.48 | Employment Agreement dated as of April 1, 2022 between Novocure (Israel) Ltd. and Barak Ben-Arye# |
|---|
| 2025-02-27 | 10-K | 10.9 | 2024 Omnibus Incentive Plan - Swiss Sub Plan# |
|---|
| 2024-12-17 | 8-K/A | 10.2 | Employment Agreement between Asaf Danziger and Novocure (Israel) Ltd. effective as of January 1, 2025 |
|---|
| 2024-12-17 | 8-K/A | 10.1 | Employment Agreement between Ashley Cordova and Novocure GmbH effective as of January 1, 2025 |
|---|
| 2024-10-30 | 8-K | 10.1 | Employment Agreement dated as of January 1, 2025 by and between Christoph Brackmann and Novocure GmbH |
|---|
| 2024-09-03 | 8-K | 10.1 | Employment Agreement between Wilhelmus Groenhuysen and Novocure USA LLC effective as of October 1, 2024 |
|---|
| 2024-06-10 | 8-K | 10.1 | NovoCure Limited 2024 Omnibus Incentive Plan |
|---|
| 2024-05-02 | 10-Q | 10.1 | Loan Agreement dated April 29. 2024 among Novocure Luxembourg S.a.r.l., the subsidiary guarantors party thereto, BPCR Limited Partnership and BioPharma Credit Investments V (Master) LP, and BioPharma Credit PLC, as collateral agent.1 |
|---|
| 2024-02-22 | 10-K | 10.23 | Non-Employee Director Compensation Program# |
|---|
| 2024-01-04 | 8-K | 10.2 | Shah Employment Agreement# |
|---|
| 2024-01-04 | 8-K | 10.1 | Leonard Employment Agreement# |
|---|
| 2023-05-04 | 10-Q | 10 | Employment Agreement, dated as of May 3, 2023, by and between NovoCure USA LLC and Francis Leonard# |
|---|
| 2022-07-28 | 10-Q | 10.2 | Non-Employee Director Compensation Program effective April 26, 2022# |
|---|
| 2022-05-26 | 8-K | 10.1 | Clinical Trial Collaboration and Supply Agreement dated May 18, 2022 by and among Novocure GmbH, Merck International GmbH and MSD International Business GmbH* |
|---|
| 2022-04-07 | 8-K | 10.1 | Employment Agreement, dated as of April 1, 2022, by and between NovoCure USA LLC and Todd Longsworth |
|---|
| 2022-02-24 | 10-K | 10.43 | Amendment No. 1 dated as of December 6, 2021 to Credit Agreement dated as of November 6, 2020 |
|---|
| 2022-02-24 | 10-K | 10.42 | Construction Agreement dated December 30, 2021 by and between Hanover Development Corporation and Novocure Inc.** |
|---|
| 2022-02-24 | 10-K | 10.41 | Purchase and Sale Agreement dated December 1, 2021 by and between 64 Vaughan Mall, LLC and Novocure Inc. |
|---|
| 2021-04-29 | 10-Q | 10.2 | Non-Employee Director Compensation Program# |
|---|
| 2021-04-29 | 10-Q | 10.1 | Employment Agreement, dated as of February 3, 2017 by and between Novocure USA LLC and Todd Longsworth# |
|---|
| 2021-02-25 | 10-K | 10.40 | First Addendum dated June 9, 2020 to License and Collaboration Agreement, dated as of September 10, 2018, between NovoCure Limited and Zai Lab (Shanghai) Co., Ltd.** |
|---|
| 2021-02-25 | 10-K | 10.23 | Amendment #1 to Employment Agreement between Novocure USA LLC and William F. Doyle dated February 24, 2021# |
|---|
| 2020-11-09 | 8-K | 10.1 | Credit Agreement dated November 6, 2020 among NovoCure Limited, the subsidiary borrowers party thereto, the lenders party thereto and J.P. Morgan Chase Bank, N.A., as administrative agent.1 |
|---|
| 2020-08-13 | 8-K | 10.3 | Employment Agreement, dated as of September 1, 2020, by and between Michael Ambrogi and Novocure USA LLC |
|---|
| 2020-08-13 | 8-K | 10.2 | Employment Agreement, dated as of September 1, 2020, by and between Ashley Cordova and Novocure USA LLC |
|---|
| 2020-08-13 | 8-K | 10.1 | Employment Agreement, dated as of September 1, 2020, by and between Wilco Groenhuysen and Novocure USA LLC |
|---|
| 2020-03-06 | 8-K | 10.2 | Form of Performance-Based Share Unit Award for Certain Executive Officers |
|---|
| 2020-03-06 | 8-K | 10.1 | Form of Performance-Based Share Unit Award for Executive Chairman and Chief Executive Officer |
|---|
| 2019-07-25 | 10-Q | 10.1 | EX-10.1 PRESS RELEASE |
|---|
| 2019-05-02 | 10-Q | 10.4 | EX-10.4 NON QUALIFIED SO SWEDEN |
|---|
| 2019-05-02 | 10-Q | 10.3 | EX-10.3 RSU AWARD SWEDEN |
|---|
| 2019-05-02 | 10-Q | 10.2 | EX-10.2 NON QUALIFIED SO AUSTRIA |
|---|
| 2019-05-02 | 10-Q | 10.1 | EX-10.1 - RSU AWARD AUSTRIA |
|---|
| 2018-10-25 | 10-Q | 10.2 | EX-10.2 ZAI LAB LICENSE AND COLLABORATION AGREEMENT |
|---|
| 2018-10-25 | 10-Q | 10.1 | EX-10.1 SHAH EMPLOYMENT AGREEMENT |
|---|
| 2018-04-26 | 10-Q | 10.1 | EX-10.1 LOAN AND SECURITY AGREEMENT |
|---|
| 2018-04-26 | 8-K | 10.1 | EX-10.1 NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM |
|---|
| 2018-04-04 | 8-K | 10.2 | Form of Restricted Share Unit Award Notice pursuant to the 2015 Omnibus Incentive Plan – Form of Agreement for Germany |
|---|
| 2018-04-04 | 8-K | 10.1 | Form of Incentive Stock Option Agreement pursuant to the NovoCure Limited 2015 Omnibus Incentive Plan – Form of Performance Option Agreement for Israel |
|---|
| 2017-10-05 | 8-K | 10.1 | Third Amendment to Loan and Security Agreement, dated as of September 27, 2017, by and between the Company and BioPharma Secured Investments III Holdings Cayman LP |
|---|
| 2017-05-12 | 8-K | 10.2 | EX-10.2 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT |
|---|
| 2017-05-12 | 8-K | 10.1 | EX-10.1 FORM OF INCENTIVE STOCK OPTION AGREEMENT |
|---|
| 2017-03-31 | 8-K | 10.1 | EX-10.1 BIOPHARMA SECOND AMENDMENT |
|---|
| 2017-02-23 | 10-K | 10.31 | EX-10.31 FORM OF RSU - JAPAN |
|---|
| 2017-02-23 | 10-K | 10.30 | EX-10.30 FORM OF RSU - SWITZERLAND |
|---|
| 2017-02-23 | 10-K | 10.29 | EX-10.29 FORM OF RSU - ISRAEL |
|---|
| 2017-02-23 | 10-K | 10.28 | EX-10.28 FORM OF RSU - USA |
|---|
| 2017-02-23 | 10-K | 10.27 | EX-10.27 EILON KIRSON EMPLOYMENT AGREEMENT |
|---|
| 2016-12-30 | 8-K | 10.2 | EX-10.2 FIRST AMENDMENT TO BIOPHARMA AGREEMENT |
|---|
| 2016-12-30 | 8-K | 10.1 | EX-10.1 LEUNG AMENDMENT TO EMPLOYMENT AGREEMENT |
|---|
| 2016-10-14 | 8-K | 10.3 | EX-10.3 AMBROGI EMPLOYMENT AGREEMENT |
|---|
| 2016-10-14 | 8-K | 10.2 | EX-10.2 GROENHUYSEN EMPLOYMENT AGREEMENT |
|---|
| 2016-10-14 | 8-K | 10.1 | EX-10.1 DANZIGER EMPLOYMENT AGREEMENT |
|---|
| 2016-07-28 | 10-Q | 10.1 | Non-Employee Director Compensation Program |
|---|
| 2016-06-30 | 8-K | 10.1 | EX-10.1 ISRAELI SUBPLAN TO THE NOVOCURE LIMITED EMPLOYEE SHARE PURCHASE PLAN |
|---|
| 2016-05-13 | 8-K | 10.1 | EX-10.1 DOYLE EMPLOYMENT AGREEMENT |
|---|
| 2016-05-10 | 10-Q | 10.1 | Employment Agreement with Michael Ambrogi and the Company, dated December 30, 2010 # |
|---|
| 2016-03-22 | 8-K | 10.1 | EX-10.1 FORM OF INDEMNIFICATION AGREEMENT |
|---|
| 2015-12-22 | 8-K | 10.5 | Form of Incentive Stock Option Agreement pursuant to the 2015 Omnibus Incentive Plan for use in Japan |
|---|
| 2015-12-22 | 8-K | 10.4 | Form of Stock Option Award Agreement based on the 2015 Omnibus Incentive Plan for use in connection with the 2015 Omnibus Incentive Plan Sub-Plan for Switzerland |
|---|
| 2015-12-22 | 8-K | 10.3 | Form of Incentive Stock Option Agreement pursuant to the 2015 Omnibus Incentive Plan for use in connection with the 2015 Omnibus Incentive Plan Sub-Plan for Grantees Subject to Israeli Taxation (102(b) grants) |
|---|
| 2015-12-22 | 8-K | 10.2 | Form of Incentive Stock Option Agreement pursuant to the 2015 Omnibus Incentive Plan for use in connection with the 2015 Omnibus Incentive Plan Sub-Plan for Grantees Subject to Israeli Taxation (non-102(b) grants) |
|---|
| 2015-12-22 | 8-K | 10.1 | 2015 Omnibus Incentive Plan, including 2015 Omnibus Incentive Plan Sub-Plan for Grantees Subject to Israeli Taxation and 2015 Omnibus Incentive Plan Sub-Plan for Switzerland |
|---|